Special items: Ovarian Cancer and Us blog best viewed in Firefox

Saturday, February 06, 2010

Incidence and management of bevacizumab-associated gastrointestinal perforations in patients with recurrent ovarian carcinoma

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.